Russian health-care watchdog Roszdravnadzor told the daily Kommersant on August 22 that U.S pharmaceutical company MSD (Merck Corporation) will stop supplying Russia with the popular Zepatier hepatitis C medicine after its planned deliveries end in late 2024. After Russian launched its full-scale invasion of Ukraine in February 2022, MSD stopped supplying Russia with Raltegravir, a medicine to decrease the chances that HIV-infected people will develop AIDS. Another Russian periodical, Vedomosti, reported that the popular Japanese garments retailer Uniqlo had stopped its operations in Russia. To read the original stories by RFE/RL's Russian Service, click here.
U.S Pharmaceutical Company To Stop Supplying Russia With Popular Hepatitis Drug
Editors' Picks
RFE/RL has been declared an "undesirable organization" by the Russian government.
If you are in Russia or the Russia-controlled parts of Ukraine and hold a Russian passport or are a stateless person residing permanently in Russia or the Russia-controlled parts of Ukraine, please note that you could face fines or imprisonment for sharing, liking, commenting on, or saving our content, or for contacting us.
To find out more, click here.